PARIS, France—A novel left atrial appendage occlusion (LAAO) device, the AnchorMan (MicroPort), has provided results similar to those seen with the Watchman (Boston Scientific) in the SAFE PROTECT ...
(Updated) SAN FRANCISCO, California — Preliminary data from the PREVAIL study of the Watchman (AtriTech/Boston Scientific) device for the prevention of stroke and systemic embolism in patients with ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Rates of patency and device-related thrombus were ...
Boston Scientific also foresees future growth in its Watchman business from a planned label expansion and concomitant ...
ORLANDO, Fla. — A novel device to treat a common heart problem that can lead to stroke showed promise in testing, but not without risk, new research shows. The experimental device, called the Watchman ...
BOSTON, MA—For patients with atrial fibrillation who are undergoing left atrial appendage occlusion (LAAO), the Amplatzer Amulet (Abbott) and the first-generation Watchman 2.5 (Boston Scientific) ...
Apr. 9—Medical Center Hospital is proud to announce that Dr. Manohar Angirekula, Dr. Adam Farber and Dr. Fernando Boccalandro successfully implanted the first WATCHMAN FLX Pro Device on April 1. MCH ...
Shaped like a small jellyfish or pumpkin no bigger than the size of a ping pong ball, the WATCHMAN device helps prevent stroke in people with atrial fibrillation (A-fib) by sealing off part of the ...
The Amplatzer Amulet (Abbott) and first-generation Watchman 2.5 (Boston Scientific) devices provide relatively comparable results out to 3 years after left atrial appendage occlusion (LAAO), longer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback